Changes at Help 4 HD due to COVID-19 (coronavirus)Michael SabadoMar 17, 20201 min readhttps://video.wixstatic.com/video/285cf2_8b8f00c3feb24d77a6e544e525fb1d27/720p/mp4/file.mp4A message from Help 4 HD International's CEO, Katie Jackson. This message will be transcribed and available here shortly.
Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
Comments